Thuethan Prasobchoke
8h ·
ลาวผลิตยาเม็ดต้านโควิด molnupiravir ที่ได้รับอนุญาตจากบริษัท Pfizer (น่าจะเป็น Merck) ออกมาขายให้ประชาชนลาวได้แล้ว ในราคาต่อคอร์ส 40 แคปซูลที่ 400000กีบ หรือเป็นเงินไทยประมาณ 1,200 บาท/คอร์ส
ส่วนประเทศไทยไม่ได้อยู่ในกลุ่มประเทศที่ได้รับอนุญาตให้ผลิตยาดังกล่าวนี้
...
Molnupiravir, sold under the brand name Lagevrio among others, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.[1]
Molnupiravir is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral action through introduction of copying errors during viral RNA replication.[6][7]
Molnupiravir was originally developed to treat influenza at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory (DRIVE), but was reportedly abandoned for mutagenicity concerns.[8][9] It was then acquired by Miami-based company Ridgeback Biotherapeutics, which later partnered with Merck & Co. to develop the drug further.[10]
Source: Wikipedia
How Molnupiravir Works: An Animated Explanation
Nov 18, 2021
Emory University
Molnupiravir is an investigational oral COVID-19 drug invented and developed by scientists at Emory University. In this video animation, we explain how it works.
Emory University
Molnupiravir is an investigational oral COVID-19 drug invented and developed by scientists at Emory University. In this video animation, we explain how it works.
Emory University
